Combigan — Class II drug recall D-1056-2019
Terminated recall by Allergan Sales, LLC, reported 2019-04-03, distributed in TN. cGMP Deviations
| Recall number | D-1056-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Allergan Sales, LLC, Waco, TX, United States |
| Recall initiated | 2019-03-19 |
| Classified | 2019-03-22 |
| Reported by FDA | 2019-04-03 |
| Terminated | 2020-04-29 |
| Distributed | TN |
| Quantity | 72 bottles |
| Reason classes | cgmp |
| NDC | 00023-9211, 00023-9211-03, 00023-9211-05, 00023-9211-10, 00023-9211-15 |
| Lot numbers | 99946 |
| Expiration dates | 2021-01-16 |
Product
Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% 5 mL bottles, Rx only, Allergan, Inc. Irvine, CA 92612 U.S.A. NDC 0023-9211-05
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1056-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.